Tango Therapeutics CEO to speak at Guggenheim Healthcare Innovation Conference Nov 10

Tango Therapeutics announced that CEO Malte Peters will participate in a fireside chat at Guggenheim's 3rd Annual Healthcare Innovation Conference on November 10, 2026. The event will be webcast live and archived on the company's website. Tango Therapeutics is a clinical-stage biotech firm focused on targeted cancer therapies, including treatments for pancreatic cancer. This appearance highlights the company's ongoing efforts to advance its pipeline and engage with investors and the healthcare community.

Tango Therapeutics holds a market capitalization of $3.67 billion and an enterprise value of $2.69 billion as of November 3, 2026, 19:02 WIB. On Pluang, the stock price is USD 21.77 with a minimal 1-day change of +0.05%, while trading volume reached 3,681,750 shares. Despite the company’s active engagement in healthcare innovation events, Pluang order activity currently shows 100% sell interest at this time.